In a regulatory filing, Procept BioRobotics disclosed that its CFO Kevin Waters sold 30K shares of common stock on March 7th in a total transaction size of $1.03M.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRCT:
- Procept BioRobotics announces Aquablation Therapy received MIB from NICE
- PROCEPT BioRobotics Corp. to Present at the Virtual Key Bank Life Sciences & MedTech Investor Forum
- Procept BioRobotics sees FY23 revenue approximately $125M, consensus $125.56M
- Procept BioRobotics reports Q4 EPS (63c), consensus (54c)
- PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2022 Results
